Mind Medicine (MindMed) Inc.
NASDAQ:MNMD
6.08 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kosten van de omzet
| 3.162 | 3.223 | 2.616 | 0 | 0.007 | 0.007 | 0.006 | 0 | 0 |
| Brutowinst
| -3.162 | -3.223 | -2.616 | 0 | -0.007 | -0.007 | -0.006 | 0 | 0 |
| Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 48.962 | 36.169 | 34.789 | 18.631 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 41.742 | 30.162 | 59.065 | 14.399 | 0 | 0 | 0 | 0 | 0 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 41.742 | 30.162 | 59.065 | 14.399 | 0.462 | 0.855 | 1.23 | 0.111 | 0.095 |
| Overige kosten
| 0 | 0.002 | 0.106 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 90.704 | 66.331 | 93.854 | 33.03 | 0.462 | 0.855 | 1.23 | 0.111 | 0.095 |
| Bedrijfsresultaat
| -93.866 | -66.331 | -96.364 | -33.03 | -0.468 | -0.862 | -1.235 | -0.111 | -0.095 |
| Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| -1.866 | 9.535 | 2.171 | -0.907 | -0.648 | 0.004 | 0.008 | -0.069 | 0.002 |
| Inkomen voor belasting
| -95.732 | -56.796 | -94.193 | -33.937 | -1.116 | -0.858 | -1.227 | -0.18 | -0.093 |
| Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Belastingkosten
| 0 | -9.535 | -1.157 | 0.164 | -0 | -0 | -0 | 0 | -0 |
| Nettowinst
| -95.732 | -47.261 | -93.036 | -34.101 | -1.116 | -0.858 | -1.227 | -0.18 | -0.093 |
| Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -2.44 | -1.53 | -3.4 | -1.92 | -2.94 | -2.74 | -4.85 | -2.24 | -1.17 |
| Verwaterde WPA
| -2.44 | -1.53 | -3.4 | -1.92 | -2.94 | -2.74 | -4.85 | -2.24 | -1.17 |
| EBITDA
| -90.704 | -74.369 | -93.748 | -33.03 | -0.462 | -0.855 | -1.23 | -0.111 | -0.095 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |